Alkermes plc. Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Alkermes plc. (ALKS) had Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year of $5.78 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear · last filed 2026-07-28
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $5.78M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $8.68M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $2.58M.
- 2025-06-30: Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year $5.15M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year |
|---|---|
| 2026-06-30 | $5.78M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $8.68M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $2.58M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $5.15M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $7.68M 10-Q · filed 2025-05-01 |
| 2024-09-30 | $2.55M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $5.07M 10-Q · filed 2024-07-24 |
| 2024-03-31 | $7.61M 10-Q · filed 2024-05-01 |
| 2023-09-30 | $4.10M 10-Q · filed 2023-10-25 |
| 2023-06-30 | $8.21M 10-Q · filed 2023-07-26 |
| 2023-03-31 | $12.31M 10-Q · filed 2023-04-26 |
| 2022-12-31 | $16.66M 10-Q · filed 2023-07-26 |
| 2022-09-30 | $4.49M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $9.01M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $13.56M 10-Q · filed 2022-04-27 |
| 2021-09-30 | $4.37M 10-Q · filed 2021-10-27 |
| 2021-06-30 | $8.79M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $12.87M 10-Q · filed 2021-04-28 |
| 2020-09-30 | $4.33M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $9.28M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $13.69M 10-Q · filed 2020-04-29 |
| 2019-09-30 | $2.22M 10-Q · filed 2019-10-23 |
| 2019-06-30 | $4.49M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $6.81M 10-Q · filed 2019-04-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |